Aytu Biopharma Inc reports results for the quarter ended in September - Earnings Summary

Aytu Biopharma

16/11/2021 03:06

* Aytu Biopharma Inc  AYTU.OQ  reported a quarterly adjusted
loss of $1.09​​ per share for the quarter ended in September.
The mean expectation of two analysts for the quarter was for a
loss of 49 cents per share.
* Revenue rose 62% to $21.90 million from a year ago;  analysts
expected $22.10 million. 
* Aytu Biopharma Inc's reported EPS for the quarter was a loss
of $1.09​.
* The mean earnings estimate of analysts had fallen by
about 226.7% in the last three months.​ 
* In the last 30 days one analyst negatively revised an earnings
estimate 
* Aytu Biopharma Inc shares had fallen by 14.2% this quarter and
lost 58.7% so far this year.
* The company reported quarterly net income of $27.85 million.
* Wall Street's median 12-month price target for Aytu Biopharma
Inc is $17.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 16 at 03:06 a.m.
 ​All figures in US dollars unless otherwise stated